RPTOR and cancer: Anti-cancer compounds targeting mTORC1, such as rapamycin, curcumin, etoposide, cisplatin, staurosporine and FasL, initiated apoptosis in various lymphoma cell lines and promoted the detection of a raptor-cleaved fragment of 100 kDa.